Newsroom

NORWALK, Conn.--(BUSINESS WIRE)--Saber-Hightower and Granoff Real Estate JV closes on $120 Million office-to-residential conversion project....

ST. LOUIS--(BUSINESS WIRE)--Copeland, un fornitore globale di tecnologie di compressione e soluzioni di controllo, ha annunciato oggi che Gwen Cheramy entrerà a far parte dell'azienda in qualità di Presidente della sua divisione europea a partire dal 1º ottobre 2026, e che Sandro Matic assumerà il ruolo di Presidente della divisione Americhe a partire dal 1º settembre 2026. Matic continuerà a guidare la divisione europea in via provvisoria fino a quando Cheramy entrerà a far parte di Copeland....

LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay Wolke & Rotter LLP reminds investors of the upcoming October 20, 2026 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Taboola.com Ltd. (“Taboola” or the “Company”) (NASDAQ: TBLA) securities between May 6, 2026 and August 4, 2026 inclusive (the “Class Period”).IF YOU SUFFERED A LOSS ON YOUR TABOOLA.COM LTD. INVESTMENTS, CLICK HERE TO INQUIRE ABOUT POTENTIALLY PURSUING CLA...

ST. LOUIS--(BUSINESS WIRE)--Copeland, een wereldwijde leverancier van compressietechnologieën en besturingsoplossingen, heeft vandaag bekendgemaakt dat Gwen Cheramy op 1 oktober 2026 bij het bedrijf in dienst treedt als president van de Europese organisatie. Sandro Matic neemt op 1 september 2026 de functie van president van de Amerikaanse activiteiten op zich. Matic blijft tot de komst van Cheramy bij Copeland op interim-basis leiding geven aan de Europese organisatie. "Sandro en Gwen zijn all...

SCHENECTADY, N.Y.--(BUSINESS WIRE)--United States Department of Transportation Secretary Sean P. Duffy traveled to the Capital Region on Monday, Aug. 24, 2026, to visit SUNY Schenectady County Community College and tour the Air Traffic Control Simulator Lab on campus while speaking with faculty and current students in the FAA-approved Enhanced Air Traffic–Collegiate Training Initiative (AT-CTI) degree program. SUNY Schenectady launched the degree program in Fall 2025 and is one of only 11 colle...

LONDON--(BUSINESS WIRE)--AM Best has affirmed the Financial Strength Rating of B- (Fair) and the Long-Term Issuer Credit Rating of “bb-” (Fair) of Life Insurance Company Centras Life JSC (Centras Life) (Kazakhstan). The outlook of these Credit Ratings (ratings) is stable.The ratings reflect Centras Life’s balance sheet strength, which AM Best assesses as strong, as well as its adequate operating performance, very limited business profile and marginal enterprise risk management.Centras Life’s bal...

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP reminds investors that a securities class action has been filed on behalf of all persons and entities that purchased or otherwise acquired Pheton Holdings Ltd (NASDAQ: PTHL) (n/k/a iTonic Holdings Ltd. (NASDAQ: ITOC)) securities between September 5, 2024 and July 29, 2025 (the "Class Period"). On January 13, 2026, the Company announced it was changing its name to iTonic Holdings Ltd. and changing its ticker symbol to ITOC effective January 16, 2026.The law...

SAINT-LOUIS--(BUSINESS WIRE)--Copeland, un fournisseur mondial de technologies de compression et de solutions de contrôle, a annoncé aujourd’hui que Gwen Cheramy rejoindrait l’entreprise en tant que présidente de la division Europe le 1er octobre 2026, et que Sandro Matic prendrait les fonctions de président de la division Amériques à compter du 1er septembre 2026. M. Matic continuera à diriger la division Europe à titre intérimaire jusqu’à l’arrivée de Mme Cheramy chez Copeland. « Sandro et Gw...

LONDRES--(BUSINESS WIRE)--VirTus Respiratory Research Ltd, una organización especializada en investigación por contrato (CRO) en el ámbito respiratorio, fundada por los investigadores del Imperial College de Londres, el profesor Sebastian Johnston y el doctor Michael Edwards, ha destacado hoy su papel en el desarrollo preclínico del APL-10456 de Apollo Therapeutics y el Imperial, tras el anuncio de los datos iniciales positivos del ensayo clínico de fase I de la vacuna. VirTus ha trabajado en e...

LONDEN--(BUSINESS WIRE)--VirTus Respiratory Research Ltd, een CRO (contract research organisation) gespecialiseerd in geneesmiddelen voor de luchtwegen opgericht door professor Sebastian Johnston en Dr. Michael Edwards, onderzoekers van de Imperial College London, belichtte vandaag de rol van de organisatie in de preklinische ontwikkeling van Apollo Therapeutics’ en Imperial’s APL-10456, na de aankondiging van positieve eerste gegevens uit de Fase 1 klinische studie van het vaccin. VirTus werkt...